Journal of Pharmacovigilance

Conference Series LLC Joint International Event on 7^th Pharmacovigilance & Pharmaceutical Industry

August 22-24, 2016 Vienna, Austria

Posters & Accepted Abstracts

• Falsified medicines: Past, present and future

  Julia Lain-Abril

  PDF HTML

• C1- inhibitors (Berinert ®) versus icatibant in the treatment of hereditary angioedema

  Silvia Leone and Francesca Mattioli

  PDF HTML

• Development of HPLC-UV/MS-MS methods applied to the quality control of Ursodeoxycholic acid in oral liquid pediatric formulations and raw material

  Boscolo O, Flor S, Martinefski M, Buontempo F, Tripodi V and Lucangioli S

  PDF HTML

• Architectural plans in drug facilities are the first step to attain safer drug industry

  Huraiz Saria Galal and Medani Amna Beshir

  PDF HTML

• Specialized US Food and Drug Administration investigators for enhanced protection of public health

  Chrissy J Cochran, Kavita C Dada, Jan L Hewett, David C Burrow and Sean Y Kassim

  PDF HTML

• Nimesulide benefit-risk assessment: How to keep under control the safety profile of a mature drug?

  Mario Bertazzoli

  PDF HTML

• Pharmacological evaluation of α-1-adrenolytics in patients diagnosed with benign prostatic hyperplasia

  Tomasz ZÄ?bkowski

  PDF HTML

• Synthesis of novel chromene derivatives of expected antitumor activity

  Manal M Kandeel, Aliaa M Kamal, Eman K A Abdelall and Heba A H Elshemy

  PDF HTML

• Aliskiren attenuated hypoxia-induced cardiac injury through activation of autophagy

  Yuh Lien Chen

  PDF HTML

• Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation

  Shahinaze A. Fouada, Rehab N. Shammab, Emad B. Basaliousb, Mohamed A. El-Nabarawib and Saadia A. Tayelb

  PDF HTML

• Can Donepezil facilitate weaning from mechanical ventilation in difficult to wean patients? An interventional pilot study

  Kamran Fazel

  PDF HTML

• Design and manufacture of applicable delivery system for toxic drugs

  Zhijun Yang

  PDF HTML

• Healthcare system across Europe and USA: The market-access agreement experience

  E Allocati, M Ciulla and A Di Stefano

  PDF HTML

• A study to determine UK undergraduate pharmacy students awareness and understanding of adverse drug reaction reporting

  Parvinder K Dalay and Bruce Burnett

  PDF HTML

• Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy - The Prevail Trial

  Djouhar Roufeida Belgaid

  PDF HTML

• United States Food and Drug Administration Postmarketing Adverse Drug Experience (PADE) inspections and the most frequently cited deviations from federal regulations

  Kelley M Simms and Namita Kothary

  PDF HTML

• Safety database updates: Past and future trends driving the decision to upgrade

  Amanda Bowles

  PDF HTML

• Hospitals adherence to the sterile preparation compounding standards in Riyadh, Saudi Arabia

  Salma Alkhani, Latifah Aldulaymi, Bashayr Alsuwayni, Mansour Adam and Nora Kalagi

  PDF HTML

• Synthesis and biological studies of new anti-inflammatory agents based NSAID core structures

  Shaaban K Mohamed

  PDF HTML

• The role of multimodal acting drugs

  Dafin F Muresanu

  PDF HTML

• Alprazolam potentiates analgesic effect of Ibuprofen in postendodontic pain

  Mahmoud Baradaran, Mahmoud Reza Hamidi, Mohammad Reza Moghimi Firoozabad, Sohrab Kazemi, Manouchehr Ashrafpour and Ali Akbar Moghadamnia

  PDF HTML

• Novel instantly-soluble transmucosal matrix using dual mechanism solubilizer for sublingual and nasal delivery of Dapoxetine Hydrochloride: In vitro/in vivo evaluation

  Shahinaze A Fouad, Rehab N Shamma, Emad B Basalious, Mohamed A El-Nabarawi and Saadia A Tayel

  PDF HTML

• Regional energy resilience dealing with fossil energy shortages

  Susanna Erker and Gernot Stoeglehner

  PDF HTML

• Introducing methodological procedures to improve detection and reporting of adverse drug reactions (ADRs) in oncological hospitals

  Baldo Paolo, Francescon Sara, Polesel Jerry, Taborelli Martina and Fornasier Giulia

  PDF HTML

• Understanding the US medical device premarket notification review process

  Heather Rosecrans

  PDF HTML

• Pharmacovigilance in Italy: An Italian experience

  Silvia Leone and Francesca Mattioli

  PDF HTML

• Smart regulation therapies challenges and opportunities: In future pharma industries

  Sugapriya Dhanasekaran

  PDF HTML

• Evaluating the attitudes of pharmacy student in the University of Umm Al-qurah, Holy city of Makkah, Saudi Arabia towards their pharmacovigilance module

  Naif Al-Hazmi

  PDF HTML

• Quality and bioequivalence of modified release products regulatory aspects

  Muhaned Al-Hindawi

  PDF HTML

• Biofilm - Formation and remediation strategies

  Michael Gietl

  PDF HTML

• Practical solutions for key problems of structural pharmacoinformatics: Hydration structure of the drug-target interface and blind docking

  Csaba Hetenyi

  PDF HTML

• The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma

  Nira Ben-Jonathan

  PDF HTML

• Heterogeneity in the relationship between competition and innovation: A quantile approach

  Giovanni Alberto Tabacco

  PDF HTML

• ATP axis in chronic obstructive pulmonary diseases: Opportunities for novel drugs development

  Amir Pelleg

  PDF HTML

• G protein/KCa/VDC channel linkage as a therapeutic target for asthma and COPD

  Hiroaki Kume

  PDF HTML